Label Changes for:

Pegasys (interferon alfa 2a)

December 2008

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

 

Sections Modified

MEDICATION GUIDE

... revised to include the risk of cerebrovascular complications due to stroke.

...statement about calling the FDA 800 number to report side effects

Hide
(web2)